BMRN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BioMarin Pharmaceutical (BMRN) Earnings Date & Reports

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BMRN is expected to report earnings to fall 23.49% to 70 cents per share on April 23

BioMarin Pharmaceutical BMRN Stock Earnings Reports

Q1'25

Est.

$0.70

Q4'24

Beat

by $0.37

Q3'24

Beat

by $0.38

Q2'24

Beat

by $0.61

Q1'24

Beat

by $0.39

The last earnings report on February 19 showed earnings per share of 92 cents, beating the estimate of 55 cents. With 1.71M shares outstanding, the current market capitalization sits at 11.51B.

View a ticker or compare two or three

Compare

BMRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BMRN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BMRN (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

770 Lindaro Street

Phone

+1 415 506-6700

Employees

3401

Web

https://www.biomarin.com